Stock CGON CG ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages CG Oncology, Inc.

Equities

CGON

US1569441009

Delayed Nasdaq
Other stock markets
 03:49:03 2024-06-10 pm EDT 		5-day change 1st Jan Change
35.19 USD +0.83% Intraday chart for CG Oncology, Inc. -2.30% 0.00%
Jun. 06 CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC CI
May. 24 Sector Update: Health Care Stocks Softer in Friday Afternoon Trading MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
Sector Update: Health Care Stocks Softer in Friday Afternoon Trading
CG Oncology Shares Jump After Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint
CG Oncology Says Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint
CG Oncology, Inc. to Present Positive Final Results from Phase 2 Core-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC At Asco 2024 Annual Meeting
CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CG Oncology, Inc. Announces Data from the Phase 3 BOND-003 Study Evaluating the Efficacy and Safety of Cretostimogene Monotherapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette Guerin
PACS Group to raise $450 mln in US IPO at over $3 bln valuation
CG Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
Fractyl Health valued at $654.6 mln in tepid debut
Fractyl Health prices US IPO below range to raise $110 mln
Fractyl Health targets up to $762 mln valuation in US IPO
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGON Stock
  4. News CG Oncology, Inc.
  5. Other languages